Results

Total Results: 1,524 records

Showing results for "drugs".

161. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
     November 01, 2023 - update for baclofen and 7 new trials for topiramate, and a small number of studies reported on some drugs … With the help of our technical expert panel, we limited drugs with off-label uses to those that are … Therefore, some drugs reviewed as emerging therapies and some only available outside the United States … In terms of results, our assessment of the effects of those drugs with Food and Drug Administration

162. Appendix A: Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-appendix-a.pdf
     September 26, 2023 - alternative medicine/ 12 exp Dietary Supplements/ 13 exp Integrative Medicine/ 14 Hallucinogenic Drugs … "dialectical behavioural therap*" or Digital or dimethyltryptamine or DMT or doximity or drug or drugs … OR "dialectical behavioural therap*" OR Digital OR dimethyltryptamine OR DMT OR doximity OR drug OR drugs

163. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

164. Evidence Summary CER 208 Treatment For Bipolar Disorder In Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
     August 01, 2018 - Some drugs aim to reduce symptoms associated with acute manic or mixed mania/depression episodes, some … For drugs not approved for BD, paliperidone also improved acute mania compared to placebo (low-strength … a number of observational studies being excluded, including those that looked at broad classes of drugs … , or individual drugs across broad populations. … However, none of the drugs reached MID.

165. S81 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
     October 01, 2007 - Nurses coded causative drugs into major classes. … Fewer classes of drugs commonly cause bleeding. … to these mechanisms are warfa- rins, heparins, antiplatelet agents, nonsteroidal anti-inflam- matory drugs … We derived a list of codes reflecting indications where guidelines17,18 dictate the use of drugs that … Development of models was greatly facilitated by focusing on the group estimated to be exposed to drugs

166. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - We have listed the included drugs and also how they were decided upon. … Only studies that evaluated one of the drugs in Table 1 were eligible. … These drugs could have been in comparison to a TCA. … to meaningfully compare drugs in this class and assess their relative harms. … Thus, it is incorrect to claim that drugs does not cause adverse events based on public data.

167. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for first-line therapy to treat AS pain. … Novartis Pharmaceuticals. 16 week efficacy and 2 year long term safety and efficacy of secukinumab … Novartis Pharmaceuticals. 16 week efficacy and 5 year long term efficacy, safety and tolerability

168. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - For example, emergency department visits related to NMU of these drugs by adults increased from 5,212 … Misuse of Prescription Drugs Research Report. 2023. … https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview. … MMWR https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview https://

169. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - most common forms of pharmacologic treatment for pain include opioids, nonsteroidal anti- inflammatory drugs … (NSAIDs), acetaminophen, topical formulations of drugs such as lidocaine, and other drugs such as antiseizure … Interventions: • Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen, muscle … , triptans) • Salicylates (topical and oral) • Topical menthol preparations • Disease-modifying drugs … Supplemental Evidence And Data for Systematic review (SEADS): Manufacturers of included drugs will be

170. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

171. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or later data were available for drugs … The experts stated oral treprostinil could be used more frequently than other drugs to treat patients

172. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Available therapies for RA include corticosteroids, oral disease-modifying antirheumatic drugs or … leflunomide, methotrexate [MTX], and sulfasalazine), and biologic DMARDs (five anti-tumor necrosis factor drugs … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … Oral DMARDs Anti-tumor necrosis factor drugs vs. … Information is also needed about the performance of these drugs in subgroups of patients defined by

173. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Safety of antiobesity drugs. Ther Adv Drug Saf. 2013;4(4):171-81. … Anti- obesity drugs: Past, present and future. Dis Model Mech. 2012 Sep;5(5):621-6.

174. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

175. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
     October 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase III trials for pharmaceuticals … study for use in the treatment of bipolar depression. 25 The drug was originally launched by King Pharmaceuticals … Drugs Future 2009;34(3):217-21. 25. Thomson Reuters Integrity [database online]. … J Psychoactive Drugs 2008 Sep;40(3):225-36. PMID: 19004414 54.

176. Medicare Prescription Drug Coverage | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/medicare-prescription-drug-coverage

177. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … These therapies are extended-release exenatide for injection (Bydureon ™ , Amylin Pharmaceuticals, … exenatide (exenatide once-weekly [EQW]; Bydureon ™ , Eli Lilly and Co., Indianapolis, IN, Amylin Pharmaceuticals … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2012 Feb 20]. [4 p]. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27. 11 p.

178. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Curr Opin Investig Drugs. 2001 Apr;2(4):505-9. PMID: 11566007 6. Tappenden K, Edelman J. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 01 [accessed 2013 Jun 05]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 21. 45 p. 14.

179. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - Treatments for gout attacks include nonsteroidal anti- inflammatory drugs (NSAIDs), colchicine, and … NSAIDs ��� ACTH = adrenocorticotropic hormone; N = number; NSAIDs = nonsteroidal anti-inflammatory drugs … the risk of gout attacks ��� N = number; NR = not reported; NSAIDs = nonsteroidal anti-inflammatory drugs … thromboembolic events, hepatic failure, TEN, SJS, and DRESS NSAIDs = nonsteroidal anti-inflammatory drugs

180. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists four topics for which (1) preliminary phase III data for drugs were … Treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs) are used for first-line therapy to … Novartis Pharmaceuticals. 16 week efficacy and 2 year long term safety and efficacy of secukinumab … Novartis Pharmaceuticals. 16 week efficacy and 5 year long term efficacy, safety and tolerability